Pen Needle, Diabetic
Brand names: 1st Tier Unifine Pentips, Advocate Pen Needle, Advocate Pen Needles, Carefine Pen Needle, Droplet Micron Pen Needle, Easy Comfort Pen Needle, Easy Comfort Pen Needles, Easy Glide Pen Needle, Embrace Pen Needle, Insulin Pen Needle, Insupen, Mini Ultra-Thin Ii, Pen Needles, Sure Comfort, Techlite Pen Needle, Ultra-Fine Micro Pen Needle, Ultra-Fine Mini Pen Needle, Ultra-Fine Original Pen Needle, Unifine Pentips Plus, Unifine Ultra Pen Needle, Verifine Plus Pen Needle, 1st Tier Unifine Pentips Plus, Clickfine, Comfort Ez Pen Needle, Comfort Touch Pen Needle, Droplet Pen Needle, Easy Touch Pen Needle, Incontrol Pen Needle, Insupen Pen Needle, Lite Touch, Maxicomfort Ii Pen Needle, Mini Pen Needle, Nano 2nd Gen Pen Needle, Novofine 32, Novofine Plus, Pen Needle, Pentips Pen Needle, Pip Pen Needle, Pro Comfort Pen Needle, Pure Comfort Pen Needle, Sure Comfort Pen Needle, True Comfort Pro Pen Needle, Trueplus Pen Needle, Ulticare Pen Needle, Ultra Flo Pen Needle, Ultra Thin, Ultra-Fine Nano Pen Needle, Ultra-Fine Short Pen Needle, Ultracare Pen Needle, Unifine Pentips, Unifine Safecontrol Pen Needle
At a glance
- Medicare prescriptions, 2024
- 2,917,591
- Medicare drug cost
- $243.6M
- Average cost per prescription
- $83.50
- Clinicians who prescribed it
- 66,736
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
No FDA prescription label was found for this drug name.
Who prescribes it
- Endocrinology & Diabetes 28.2%
- Family Medicine 22.1%
- Internal Medicine 21.1%
- Nurse Practitioners 18.1%
- Physician Assistants 5.8%
- General Practice 1.2%
- Pharmacists 0.9%
- Geriatric Medicine 0.6%
- Nephrology (Kidney) 0.4%
- Hospitalist 0.2%
- Cardiology 0.1%
- Rheumatology 0.1%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 3% from 2019 to 2024.
Biggest change by state since 2019
- Puerto Rico +97%
- Virginia +12%
- Arizona +11%
- Utah +10%
- Colorado +9%
- Oklahoma (smallest change) −19%
- Alaska (smallest change) −18%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.